We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00234689
Recruitment Status : Completed
First Posted : October 7, 2005
Last Update Posted : January 30, 2008
Information provided by:
Sheba Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2004
  Study Completion Date : December 2004